Brief: Amicus Therapeutics Announces Approval And Launch Of New Pompe Disease Therapy In The United Kingdom
15/08/2023 12:35
Amicus Therapeutics Inc FOLD.O :
* AMICUS THERAPEUTICS ANNOUNCES APPROVAL AND LAUNCH OF NEW
POMPE
DISEASE THERAPY IN THE UNITED KINGDOM
* AMICUS THERAPEUTICS - POMBILITI (CIPAGLUCOSIDASE ALFA) +
OPFOLDA
(MIGLUSTAT) APPROVED FOR ADULTS LIVING WITH LATE-ONSET POMPE
DISEASE IN GREAT BRITAIN
Source text for Eikon: ID:nGNX49mT8J
Further company coverage: FOLD.O
Recent news on Amicus Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Amicus Q4 revenue beats estimates